The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diagnostics of Peripheral Arterial Disease Market Research Report 2025
Synopsis
Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.
The global Diagnostics of Peripheral Arterial Disease market was valued at US$ 834 million in 2023 and is anticipated to reach US$ 1194.2 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostics of Peripheral Arterial Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostics of Peripheral Arterial Disease.
Report Scope
The Diagnostics of Peripheral Arterial Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostics of Peripheral Arterial Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostics of Peripheral Arterial Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Viasonix
Koven Technology
Natus Medical
Huntleigh
Hokanson
CooperSurgical
Perimed
Atys Medical
Newman Medical
Segment by Type
Ankle-Brachial Index (ABI)
Ultrasonography
Angiography
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostics of Peripheral Arterial Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.
The global Diagnostics of Peripheral Arterial Disease market was valued at US$ 834 million in 2023 and is anticipated to reach US$ 1194.2 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostics of Peripheral Arterial Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostics of Peripheral Arterial Disease.
Report Scope
The Diagnostics of Peripheral Arterial Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostics of Peripheral Arterial Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostics of Peripheral Arterial Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Viasonix
Koven Technology
Natus Medical
Huntleigh
Hokanson
CooperSurgical
Perimed
Atys Medical
Newman Medical
Segment by Type
Ankle-Brachial Index (ABI)
Ultrasonography
Angiography
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostics of Peripheral Arterial Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Ankle-Brachial Index (ABI)
1.2.3 Ultrasonography
1.2.4 Angiography
1.2.5 Other
1.3 Market by Application
1.3.1 Global Diagnostics of Peripheral Arterial Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostics of Peripheral Arterial Disease Market Perspective (2019-2030)
2.2 Diagnostics of Peripheral Arterial Disease Growth Trends by Region
2.2.1 Global Diagnostics of Peripheral Arterial Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diagnostics of Peripheral Arterial Disease Historic Market Size by Region (2019-2024)
2.2.3 Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Region (2025-2030)
2.3 Diagnostics of Peripheral Arterial Disease Market Dynamics
2.3.1 Diagnostics of Peripheral Arterial Disease Industry Trends
2.3.2 Diagnostics of Peripheral Arterial Disease Market Drivers
2.3.3 Diagnostics of Peripheral Arterial Disease Market Challenges
2.3.4 Diagnostics of Peripheral Arterial Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostics of Peripheral Arterial Disease Players by Revenue
3.1.1 Global Top Diagnostics of Peripheral Arterial Disease Players by Revenue (2019-2024)
3.1.2 Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Players (2019-2024)
3.2 Global Diagnostics of Peripheral Arterial Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diagnostics of Peripheral Arterial Disease Revenue
3.4 Global Diagnostics of Peripheral Arterial Disease Market Concentration Ratio
3.4.1 Global Diagnostics of Peripheral Arterial Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostics of Peripheral Arterial Disease Revenue in 2023
3.5 Diagnostics of Peripheral Arterial Disease Key Players Head office and Area Served
3.6 Key Players Diagnostics of Peripheral Arterial Disease Product Solution and Service
3.7 Date of Enter into Diagnostics of Peripheral Arterial Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostics of Peripheral Arterial Disease Breakdown Data by Type
4.1 Global Diagnostics of Peripheral Arterial Disease Historic Market Size by Type (2019-2024)
4.2 Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Type (2025-2030)
5 Diagnostics of Peripheral Arterial Disease Breakdown Data by Application
5.1 Global Diagnostics of Peripheral Arterial Disease Historic Market Size by Application (2019-2024)
5.2 Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diagnostics of Peripheral Arterial Disease Market Size (2019-2030)
6.2 North America Diagnostics of Peripheral Arterial Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diagnostics of Peripheral Arterial Disease Market Size by Country (2019-2024)
6.4 North America Diagnostics of Peripheral Arterial Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostics of Peripheral Arterial Disease Market Size (2019-2030)
7.2 Europe Diagnostics of Peripheral Arterial Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diagnostics of Peripheral Arterial Disease Market Size by Country (2019-2024)
7.4 Europe Diagnostics of Peripheral Arterial Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size (2019-2030)
8.2 Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostics of Peripheral Arterial Disease Market Size (2019-2030)
9.2 Latin America Diagnostics of Peripheral Arterial Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diagnostics of Peripheral Arterial Disease Market Size by Country (2019-2024)
9.4 Latin America Diagnostics of Peripheral Arterial Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size (2019-2030)
10.2 Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Viasonix
11.1.1 Viasonix Company Detail
11.1.2 Viasonix Business Overview
11.1.3 Viasonix Diagnostics of Peripheral Arterial Disease Introduction
11.1.4 Viasonix Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
11.1.5 Viasonix Recent Development
11.2 Koven Technology
11.2.1 Koven Technology Company Detail
11.2.2 Koven Technology Business Overview
11.2.3 Koven Technology Diagnostics of Peripheral Arterial Disease Introduction
11.2.4 Koven Technology Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
11.2.5 Koven Technology Recent Development
11.3 Natus Medical
11.3.1 Natus Medical Company Detail
11.3.2 Natus Medical Business Overview
11.3.3 Natus Medical Diagnostics of Peripheral Arterial Disease Introduction
11.3.4 Natus Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
11.3.5 Natus Medical Recent Development
11.4 Huntleigh
11.4.1 Huntleigh Company Detail
11.4.2 Huntleigh Business Overview
11.4.3 Huntleigh Diagnostics of Peripheral Arterial Disease Introduction
11.4.4 Huntleigh Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
11.4.5 Huntleigh Recent Development
11.5 Hokanson
11.5.1 Hokanson Company Detail
11.5.2 Hokanson Business Overview
11.5.3 Hokanson Diagnostics of Peripheral Arterial Disease Introduction
11.5.4 Hokanson Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
11.5.5 Hokanson Recent Development
11.6 CooperSurgical
11.6.1 CooperSurgical Company Detail
11.6.2 CooperSurgical Business Overview
11.6.3 CooperSurgical Diagnostics of Peripheral Arterial Disease Introduction
11.6.4 CooperSurgical Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
11.6.5 CooperSurgical Recent Development
11.7 Perimed
11.7.1 Perimed Company Detail
11.7.2 Perimed Business Overview
11.7.3 Perimed Diagnostics of Peripheral Arterial Disease Introduction
11.7.4 Perimed Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
11.7.5 Perimed Recent Development
11.8 Atys Medical
11.8.1 Atys Medical Company Detail
11.8.2 Atys Medical Business Overview
11.8.3 Atys Medical Diagnostics of Peripheral Arterial Disease Introduction
11.8.4 Atys Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
11.8.5 Atys Medical Recent Development
11.9 Newman Medical
11.9.1 Newman Medical Company Detail
11.9.2 Newman Medical Business Overview
11.9.3 Newman Medical Diagnostics of Peripheral Arterial Disease Introduction
11.9.4 Newman Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
11.9.5 Newman Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Ankle-Brachial Index (ABI)
Table 3. Key Players of Ultrasonography
Table 4. Key Players of Angiography
Table 5. Key Players of Other
Table 6. Global Diagnostics of Peripheral Arterial Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Diagnostics of Peripheral Arterial Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Diagnostics of Peripheral Arterial Disease Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Diagnostics of Peripheral Arterial Disease Market Share by Region (2019-2024)
Table 10. Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Diagnostics of Peripheral Arterial Disease Market Share by Region (2025-2030)
Table 12. Diagnostics of Peripheral Arterial Disease Market Trends
Table 13. Diagnostics of Peripheral Arterial Disease Market Drivers
Table 14. Diagnostics of Peripheral Arterial Disease Market Challenges
Table 15. Diagnostics of Peripheral Arterial Disease Market Restraints
Table 16. Global Diagnostics of Peripheral Arterial Disease Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Diagnostics of Peripheral Arterial Disease Market Share by Players (2019-2024)
Table 18. Global Top Diagnostics of Peripheral Arterial Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostics of Peripheral Arterial Disease as of 2023)
Table 19. Ranking of Global Top Diagnostics of Peripheral Arterial Disease Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Diagnostics of Peripheral Arterial Disease Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diagnostics of Peripheral Arterial Disease Product Solution and Service
Table 23. Date of Enter into Diagnostics of Peripheral Arterial Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diagnostics of Peripheral Arterial Disease Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Type (2019-2024)
Table 27. Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Type (2025-2030)
Table 29. Global Diagnostics of Peripheral Arterial Disease Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Application (2019-2024)
Table 31. Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Application (2025-2030)
Table 33. North America Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Diagnostics of Peripheral Arterial Disease Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Diagnostics of Peripheral Arterial Disease Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Diagnostics of Peripheral Arterial Disease Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Diagnostics of Peripheral Arterial Disease Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Diagnostics of Peripheral Arterial Disease Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Diagnostics of Peripheral Arterial Disease Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size by Country (2025-2030) & (US$ Million)
Table 48. Viasonix Company Detail
Table 49. Viasonix Business Overview
Table 50. Viasonix Diagnostics of Peripheral Arterial Disease Product
Table 51. Viasonix Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024) & (US$ Million)
Table 52. Viasonix Recent Development
Table 53. Koven Technology Company Detail
Table 54. Koven Technology Business Overview
Table 55. Koven Technology Diagnostics of Peripheral Arterial Disease Product
Table 56. Koven Technology Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024) & (US$ Million)
Table 57. Koven Technology Recent Development
Table 58. Natus Medical Company Detail
Table 59. Natus Medical Business Overview
Table 60. Natus Medical Diagnostics of Peripheral Arterial Disease Product
Table 61. Natus Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024) & (US$ Million)
Table 62. Natus Medical Recent Development
Table 63. Huntleigh Company Detail
Table 64. Huntleigh Business Overview
Table 65. Huntleigh Diagnostics of Peripheral Arterial Disease Product
Table 66. Huntleigh Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024) & (US$ Million)
Table 67. Huntleigh Recent Development
Table 68. Hokanson Company Detail
Table 69. Hokanson Business Overview
Table 70. Hokanson Diagnostics of Peripheral Arterial Disease Product
Table 71. Hokanson Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024) & (US$ Million)
Table 72. Hokanson Recent Development
Table 73. CooperSurgical Company Detail
Table 74. CooperSurgical Business Overview
Table 75. CooperSurgical Diagnostics of Peripheral Arterial Disease Product
Table 76. CooperSurgical Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024) & (US$ Million)
Table 77. CooperSurgical Recent Development
Table 78. Perimed Company Detail
Table 79. Perimed Business Overview
Table 80. Perimed Diagnostics of Peripheral Arterial Disease Product
Table 81. Perimed Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024) & (US$ Million)
Table 82. Perimed Recent Development
Table 83. Atys Medical Company Detail
Table 84. Atys Medical Business Overview
Table 85. Atys Medical Diagnostics of Peripheral Arterial Disease Product
Table 86. Atys Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024) & (US$ Million)
Table 87. Atys Medical Recent Development
Table 88. Newman Medical Company Detail
Table 89. Newman Medical Business Overview
Table 90. Newman Medical Diagnostics of Peripheral Arterial Disease Product
Table 91. Newman Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2019-2024) & (US$ Million)
Table 92. Newman Medical Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostics of Peripheral Arterial Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Diagnostics of Peripheral Arterial Disease Market Share by Type: 2023 VS 2030
Figure 3. Ankle-Brachial Index (ABI) Features
Figure 4. Ultrasonography Features
Figure 5. Angiography Features
Figure 6. Other Features
Figure 7. Global Diagnostics of Peripheral Arterial Disease Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Diagnostics of Peripheral Arterial Disease Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Diagnostics of Peripheral Arterial Disease Report Years Considered
Figure 13. Global Diagnostics of Peripheral Arterial Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Diagnostics of Peripheral Arterial Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Diagnostics of Peripheral Arterial Disease Market Share by Region: 2023 VS 2030
Figure 16. Global Diagnostics of Peripheral Arterial Disease Market Share by Players in 2023
Figure 17. Global Top Diagnostics of Peripheral Arterial Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostics of Peripheral Arterial Disease as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Diagnostics of Peripheral Arterial Disease Revenue in 2023
Figure 19. North America Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Diagnostics of Peripheral Arterial Disease Market Share by Country (2019-2030)
Figure 21. United States Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Diagnostics of Peripheral Arterial Disease Market Share by Country (2019-2030)
Figure 25. Germany Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Share by Region (2019-2030)
Figure 33. China Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Diagnostics of Peripheral Arterial Disease Market Share by Country (2019-2030)
Figure 41. Mexico Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Share by Country (2019-2030)
Figure 45. Turkey Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Viasonix Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
Figure 48. Koven Technology Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
Figure 49. Natus Medical Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
Figure 50. Huntleigh Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
Figure 51. Hokanson Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
Figure 52. CooperSurgical Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
Figure 53. Perimed Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
Figure 54. Atys Medical Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
Figure 55. Newman Medical Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
